Clinical Trial of New Drug for Schizophrenia. Reply

Steven M. Paul; Alan Breier; Jeffrey A. Lieberman; Stephen K. Brannan; Sharon Sawchak; Andrew C. Miller

doi:10.1056/NEJMc2104965

Clinical Trial of New Drug for Schizophrenia. Reply

Steven M. Paul, Alan Breier, Jeffrey A. Lieberman, Stephen K. Brannan, Sharon Sawchak, Andrew C. Miller

Washington University School of Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e105
Journal	The New England journal of medicine
Volume	384
Issue number	25
DOIs	https://doi.org/10.1056/NEJMc2104965
State	Published - Jun 24 2021

Access to Document

10.1056/NEJMc2104965

Cite this

@article{76aac77aa6e741a393013f5157c418ce,

title = "Clinical Trial of New Drug for Schizophrenia. Reply",

author = "Paul, {Steven M.} and Alan Breier and Lieberman, {Jeffrey A.} and Brannan, {Stephen K.} and Sharon Sawchak and Miller, {Andrew C.}",

year = "2021",

month = jun,

day = "24",

doi = "10.1056/NEJMc2104965",

language = "English",

volume = "384",

pages = "e105",

journal = "The New England journal of medicine",

issn = "0028-4793",

number = "25",

}

TY - JOUR

T1 - Clinical Trial of New Drug for Schizophrenia. Reply

AU - Paul, Steven M.

AU - Breier, Alan

AU - Lieberman, Jeffrey A.

AU - Brannan, Stephen K.

AU - Sawchak, Sharon

AU - Miller, Andrew C.

PY - 2021/6/24

Y1 - 2021/6/24

UR - http://www.scopus.com/inward/record.url?scp=85109004296&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2104965

DO - 10.1056/NEJMc2104965

M3 - Letter

C2 - 34161716

AN - SCOPUS:85108677893

SN - 0028-4793

VL - 384

SP - e105

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 25

ER -

Clinical Trial of New Drug for Schizophrenia. Reply

Access to Document

Other files and links

Cite this